Laurus Labs Limited (LAURUSLABS) Earnings Call Transcripts

23 earnings calls from January 2020 to October 29, 2026

NSEI IN Health Care Pharmaceuticals

About Laurus Labs Limited

Laurus Labs Limited (LAURUSLABS) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NSEI and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 23 calls on record spanning January 31, 2020 to October 29, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 23 Laurus Labs Limited earnings call transcripts on record, spanning January 31, 2020 to October 29, 2026. Based on this history, Laurus Labs Limited reports quarterly. The most recent call on file is dated October 29, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
LAURUSLABS
Exchange
NSEI
Country
IN
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
23
First call
January 31, 2020
Most recent
October 29, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2027 Oct 29, 2026 Read transcript →
Q1 FY2027 Jul 24, 2026 Read transcript →
Q4 FY2026 Apr 30, 2026 Read transcript →
Q3 FY2026 Jan 23, 2026 Read transcript →
Q4 FY2025 Apr 24, 2025 Read transcript →
Q2 FY2025 Oct 24, 2024 Read transcript →
Q1 FY2025 Jul 25, 2024 Read transcript →
Q4 FY2024 Apr 25, 2024 Read transcript →
Q3 FY2024 Jan 24, 2024 Read transcript →
Q2 FY2024 Oct 20, 2023 Read transcript →
Q1 FY2024 Jul 27, 2023 Read transcript →
Q4 FY2023 Apr 27, 2023 Read transcript →
Q3 FY2023 Jan 30, 2023 Read transcript →
Q2 FY2023 Oct 21, 2022 Read transcript →
Q1 FY2023 Jul 28, 2022 Read transcript →
Q4 FY2022 Apr 29, 2022 Read transcript →
Q3 FY2022 Jan 28, 2022 Read transcript →
Q1 FY2022 Jul 30, 2021 Read transcript →
Q4 FY2021 Apr 30, 2021 Read transcript →
Q3 FY2021 Jan 29, 2021 Read transcript →
Q2 FY2021 Oct 30, 2020 Read transcript →
Q1 FY2021 Jul 31, 2020 Read transcript →
Q3 FY2020 Jan 31, 2020 Read transcript →